Search research articles
Contact Us
Filters
Showing results (31-40 of 217) with videos related to
Page
of 22
Sort By:
Anticancer Research
|
June 10, 2019
Should We Cease to Perform Salvage Hysterectomy After Chemoradiation and Brachytherapy in Locally Advanced Cervical Cancer?
Marie Gosset, Cyrus Chargari, Erica Bentivegna, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
March 6, 2025
Fertility results and oncologic outcomes in patients with stage II and III serous borderline ovarian tumors
Doris Célanie, Stéphanie Scherier, Amandine Maulard, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
April 2, 2015
Outcome of patients with advanced-stage borderline ovarian tumors after a first peritoneal noninvasive recurrence: impact on further management
Catherine Uzan, Anne-Sophie Zanini-Grandon, Enrica Bentivegna, et al.
Bulletin Du Cancer
|
August 12, 2023
Frédéric Selle, Florence Joly, Laurence Gladieff, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
September 23, 2024
Dynamic changes in <i>TP53</i> mutated circulating tumor DNA predicts outcome of patients with high-grade ovarian carcinomas
Maria Kfoury, Clément Bonnet, Nicolas Delanoy, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
December 9, 2025
Stage IA3 endometrial cancer in the FIGO 2023 classification: a case of clarity or complexity?
Quentin Bachelin, Houssein El Hajj, Stéphanie Scherier, et al.
Anticancer Research
|
March 31, 2018
Bevacizumab Does Not Reduce the Lymphocele Rate in Advanced Ovarian Cancer After Complete Cytoreductive Surgery
Morgane Perrin, Enrica Bentivegna, Claire Bonneau, et al.
Annals of Surgical Oncology
|
March 26, 2021
Brenner Borderline Ovarian Tumor: A Case Series and Literature Review
Giulio Ricotta, Amandine Maulard, Catherine Genestie, et al.
The Oncologist
|
September 12, 2018
Results from a Monocentric Long-Term Analysis of 23 Patients with Ovarian Sertoli-Leydig Cell Tumors
Sebastien Gouy, Alexandra Arfi, Amandine Maulard, et al.
Gynecologic Oncology
|
June 24, 2020
Long term follow-up of a large series of stage-II/III atypical proliferative serous ovarian tumors
Sophie Maria, Matthieu Faron, Amandine Maulard, et al.
Page
of 22
Search research articles
Search
Showing results (31-40 of 217) with videos related to
Sort By:
Page
of 22
Anticancer Research
|
June 10, 2019
Should We Cease to Perform Salvage Hysterectomy After Chemoradiation and Brachytherapy in Locally Advanced Cervical Cancer?
Marie Gosset, Cyrus Chargari, Erica Bentivegna, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
March 6, 2025
Fertility results and oncologic outcomes in patients with stage II and III serous borderline ovarian tumors
Doris Célanie, Stéphanie Scherier, Amandine Maulard, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
April 2, 2015
Outcome of patients with advanced-stage borderline ovarian tumors after a first peritoneal noninvasive recurrence: impact on further management
Catherine Uzan, Anne-Sophie Zanini-Grandon, Enrica Bentivegna, et al.
Bulletin Du Cancer
|
August 12, 2023
Frédéric Selle, Florence Joly, Laurence Gladieff, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
September 23, 2024
Dynamic changes in <i>TP53</i> mutated circulating tumor DNA predicts outcome of patients with high-grade ovarian carcinomas
Maria Kfoury, Clément Bonnet, Nicolas Delanoy, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
December 9, 2025
Stage IA3 endometrial cancer in the FIGO 2023 classification: a case of clarity or complexity?
Quentin Bachelin, Houssein El Hajj, Stéphanie Scherier, et al.
Anticancer Research
|
March 31, 2018
Bevacizumab Does Not Reduce the Lymphocele Rate in Advanced Ovarian Cancer After Complete Cytoreductive Surgery
Morgane Perrin, Enrica Bentivegna, Claire Bonneau, et al.
Annals of Surgical Oncology
|
March 26, 2021
Brenner Borderline Ovarian Tumor: A Case Series and Literature Review
Giulio Ricotta, Amandine Maulard, Catherine Genestie, et al.
The Oncologist
|
September 12, 2018
Results from a Monocentric Long-Term Analysis of 23 Patients with Ovarian Sertoli-Leydig Cell Tumors
Sebastien Gouy, Alexandra Arfi, Amandine Maulard, et al.
Gynecologic Oncology
|
June 24, 2020
Long term follow-up of a large series of stage-II/III atypical proliferative serous ovarian tumors
Sophie Maria, Matthieu Faron, Amandine Maulard, et al.
Page
of 22